Overall, these data support a model in which the absence of tumor myeloid cell NF‐κB p50 leads to the activation of tumor CD4+ and CD8+ T cells to slow 9464D high‐risk neuroblastoma tumor growth. This evidence concerns the gene NFKB1 and neuroblastoma.